Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial

Mise à jour : Il y a 4 ans
Référence : NCT02508649

Femme et Homme

Extrait

This is a double-blind, randomised, placebo-controlled, two-part adaptive clinical trial. The trial is designed to investigate the efficacy and safety of multiple dosing regimens of selepressin and to confirm the efficacy and safety of one dosing regimen in treatment of adult patients with septic shock requiring vasopressor.


Critère d'inclusion

  • Septic shock


Liens